R.M. Davis Inc’s West Pharmaceutical WST Stock Holding History

R.M. Davis Inc’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,086	Closed	-$356K	–	292
2024 Q4	$356K	Sell	1,086 -349	-24%	-$110K	0.01%	223
2024 Q3	$431K	Hold	1,435	–	–	0.01%	206
2024 Q2	$473K	Sell	1,435 -1	-0.1%	-$353	0.01%	199
2024 Q1	$568K	Hold	1,436	–	–	0.01%	174
2023 Q4	$506K	Hold	1,436	–	–	0.01%	182
2023 Q3	$539K	Buy	+1,436	New	+$555K	0.01%	176
2023 Q2	–	Sell	-1,436	Closed	-$498K	–	284
2023 Q1	$498K	Hold	1,436	–	–	0.01%	180
2022 Q4	$338K	Hold	1,436	–	–	0.01%	214
2022 Q3	$353K	Sell	1,436 -188	-12%	-$57.3K	0.01%	202
2022 Q2	$491K	Hold	1,624	–	–	0.01%	177
2022 Q1	$667K	Hold	1,624	–	–	0.02%	166
2021 Q4	$762K	Sell	1,624 -3	-0.2%	-$1.29K	0.02%	161
2021 Q3	$691K	Buy	1,627 +3	+0.2%	+$1.26K	0.02%	160
2021 Q2	$583K	Buy	1,624 +86	+6%	+$28.4K	0.01%	166
2021 Q1	$433K	Hold	1,538	–	–	0.01%	181
2020 Q4	$436K	Buy	+1,538	New	+$432K	0.01%	183

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

R.M. Davis Inc's WST Position: Q1 2025 in Review

R.M. Davis Inc sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 1,086 shares — an estimated $356K sold.

R.M. Davis Inc first reported a position in WST in Q4 2020 and held it in 16 quarters. The position peaked at $762K in Q4 2021. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

R.M. Davis Inc reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
R.M. Davis Inc sold 1,086 West Pharmaceutical shares in Q1 2025, an estimated $356K.
R.M. Davis Inc first reported a position in West Pharmaceutical in Q4 2020 and held it in 16 quarters.
R.M. Davis Inc's West Pharmaceutical position peaked at $762K in Q4 2021.
715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on R.M. Davis Inc's 13F filing for Q1 2025, filed 8 May 2025.